Ascensia Diabetes Care said today it inked a strategic alliance with Insulet (NSDQ:PODD) to integrate connectivity between Insulet’s next-gen Omnipod system with Ascensia’s Contour Next One blood glucose monitoring system.
Through the deal, Parsippany, N.J.-based Ascensia’s Contour Next will be designed to pair via Bluetooth with the Omnipod Dash personal diabetes manager to automatically communicate blood glucose readings directly to the system. Readings provided will be used by Insulet’s Omnipod Dash PDM to calculate insulin dosing and support delivery of insulin.
“We are thrilled to partner with Ascensia as part of our development efforts on our next-generation Omnipod Dash platform, which will allow Insulet to maintain its competitive edge with truly innovative and differentiated products,” prez & COO Shacey Petrovic said in a press release.
Insulet will develop and seek marketing clearance for its Omnipod Dash PDM with collaboration with Ascensia Diabetes Care, who will provide the Contour Next One meter and Contour Next test strips.
“We are delighted to enter into this agreement that brings together these innovative technologies from both companies. The integration of our BGM system with Insulet’s tubeless insulin pump system has significant potential to help people take control of their lives and their diabetes. We are pleased that our highly accurate system has been chosen to provide the critical blood glucose data that will be used by the Omnipod Dash PDM to calculate insulin dosing for patients. This alliance is the next step in our goal of providing integrated solutions for people living with diabetes. We believe that integrated diabetes management is the future and are happy to work with partners that will help us to achieve this goal together. One aspect of this is pump therapy, where we have established ourselves as the partner of choice for blood glucose monitoring in the pump sector. We are excited that Insulet recognizes the value the Contour Next One BGMS can bring to users of Omnipod’s product platform,” CEO Michael Kloss said in a prepared statement.
